Morel Virginie, Ghoubra Faten, Izquierdo Laure, Martin Elodie, Oliveira Catarina, François Catherine, Brochot Etienne, Helle François, Duverlie Gilles, Castelain Sandrine
Virology Research Unit, EA4294, Jules Verne University of Picardie, France; Department of Virology, Amiens University Hospital, Amiens, France.
Laboratory of Clinical Virology, Pasteur Institute of Tunis, Tunis-Belvédère, Tunisia.
Infect Genet Evol. 2016 Jun;40:374-380. doi: 10.1016/j.meegid.2015.09.030. Epub 2015 Oct 9.
Genetic recombination is now a well-established feature of the hepatitis C virus (HCV) variability and evolution, with the recent identification of circulating recombinant forms. In Amiens University Hospital Centre (France), a discrepancy of genotyping results was observed for 9 samples, between their 5' untranslated region assigned to genotype 1b and their NS5B region assigned to genotype 1a, suggesting the existence of a recombinant strain. In the present study, clinical and phylogenetic analyses of these isolates were conducted and a putative relationship with previously identified HCV 1b/1a recombinants was investigated. The results revealed that all 9 strains displayed a breakpoint within the beginning of the core protein, were closely related between each other and with the H23 strain identified in Uruguay (Moreno et al., 2009). Then, the clinical characteristics of the 9 unlinked individuals infected with this 1b/1a genotype were analysed. This is the first report on the circulation, in a French population, of a HCV recombinant strain 1b/1a. The identification of this genotype in other patients and in other geographical zones would allow to further investigate its prevalence in the population and to better understand its molecular epidemiology.
基因重组现已成为丙型肝炎病毒(HCV)变异性和进化的一个公认特征,最近已鉴定出循环重组形式。在法国亚眠大学医院中心,观察到9个样本的基因分型结果存在差异,其5'非翻译区被指定为1b基因型,而NS5B区被指定为1a基因型,这表明存在一种重组毒株。在本研究中,对这些分离株进行了临床和系统发育分析,并研究了与先前鉴定的HCV 1b/1a重组体之间的假定关系。结果显示,所有9个毒株在核心蛋白起始部位均出现一个断点,彼此之间以及与在乌拉圭鉴定出的H23毒株密切相关(Moreno等人,2009年)。然后,分析了感染这种1b/1a基因型的9名无关联个体的临床特征。这是关于HCV 1b/1a重组毒株在法国人群中传播的首份报告。在其他患者和其他地理区域鉴定出这种基因型,将有助于进一步调查其在人群中的流行情况,并更好地了解其分子流行病学。